tacrine has been researched along with neostigmine in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 5 (38.46) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Ahlin, G; Bergström, F; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Rehngren, M; Wan, H | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Ji, J; Peng, Y; Rakesh, KP; Wang, S; Xu, M; Zhu, L | 1 |
| Henriksson, BG; Järbe, TU; Johansson, JO | 1 |
| Galli, A; Gori, I; Lucherini, M; Mori, F | 1 |
| Miyamoto, MD; Provan, SD | 1 |
| Itoh, Y; Nishibori, M; Oishi, R; Saeki, K | 1 |
| Arnal, F; Coté, LJ; Ginsburg, S; Lawrence, GD; Naini, A; Sano, M | 1 |
| Dodds, HM; Rivory, LP | 1 |
| Kaur, J; Zhang, MQ | 1 |
| Ben-Hur, T; Ben-Menachem, O; Gilboa, A; Pollak, Y; Soreq, H; Yirmiya, R | 1 |
2 review(s) available for tacrine and neostigmine
| Article | Year |
|---|---|
Triazole derivatives as inhibitors of Alzheimer's disease: Current developments and structure-activity relationships.
Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Humans; Molecular Structure; Neuroprotective Agents; Structure-Activity Relationship; Triazoles | 2019 |
Molecular modelling and QSAR of reversible acetylcholines-terase inhibitors.
Topics: Alkaloids; Alzheimer Disease; Cholinesterase Inhibitors; Crystallography, X-Ray; Donepezil; Drug Design; Glaucoma; Humans; Indans; Models, Molecular; Myasthenia Gravis; Neostigmine; Physostigmine; Piperidines; Sesquiterpenes; Structure-Activity Relationship; Surface Properties; Tacrine | 2000 |
11 other study(ies) available for tacrine and neostigmine
| Article | Year |
|---|---|
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods.
Topics: Animals; Biological Transport; Brain; Chemical Phenomena; Dialysis; Hydrogen-Ion Concentration; In Vitro Techniques; Lysosomes; Male; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Tissue Distribution | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Drug discrimination in rats: the effects of phencyclidine and ditran.
Topics: Animals; Cues; Cyclohexylamines; Discrimination Learning; Drug Combinations; Fenclonine; Glycolates; Imipramine; Ketamine; Male; Neostigmine; Phencyclidine; Physostigmine; Piperidines; Pyrrolidines; Rats; Tacrine; Tetrabenazine; Yohimbine | 1975 |
In vitro protection of acetylcholinesterase and butyrylcholinesterase by tetrahydroaminoacridine. Comparison with physostigmine.
Topics: Acetylcholinesterase; Binding Sites; Butyrylcholinesterase; Cholinesterase Reactivators; Dose-Response Relationship, Drug; Isoflurophate; Neostigmine; Organophosphorus Compounds; Physostigmine; Tacrine | 1992 |
Tetrahydroaminoacridine and physostigmine have opposing effects on probability of transmitter release at the frog neuromuscular junction.
Topics: Animals; Evoked Potentials; In Vitro Techniques; Kinetics; Motor Endplate; Neostigmine; Neurotransmitter Agents; Physostigmine; Potassium; Rana pipiens; Skin; Tacrine | 1991 |
9-Amino-1,2,3,4-tetrahydroacridine is a potent inhibitor of histamine N-methyltransferase.
Topics: Animals; Brain; Cattle; Histamine; Histamine N-Methyltransferase; In Vitro Techniques; Male; Methylhistamines; Mice; Mice, Inbred Strains; Neostigmine; Physostigmine; Tacrine | 1991 |
Studies on new, centrally active and reversible acetylcholinesterase inhibitors.
Topics: Acetylcholinesterase; Animals; Blood-Brain Barrier; Brain; Cholinesterase Inhibitors; Dopamine; Male; Mice; Neostigmine; Norepinephrine; Pyridostigmine Bromide; Tacrine | 1990 |
The mechanism for the inhibition of acetylcholinesterases by irinotecan (CPT-11).
Topics: Acetylcholinesterase; Acylation; Alzheimer Disease; Binding, Competitive; Butyrylcholinesterase; Camptothecin; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Erythrocytes; Humans; Hydrolysis; Irinotecan; Kinetics; Neostigmine; Propidium; Substrate Specificity; Tacrine | 1999 |
Acetylcholinesterase inhibitors reduce brain and blood interleukin-1beta production.
Topics: Animals; Brain Chemistry; Cholinesterase Inhibitors; Hippocampus; Interleukin-1; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Neostigmine; Oligodeoxyribonucleotides; Oligonucleotides; Oligonucleotides, Antisense; Phenylcarbamates; Rivastigmine; Tacrine | 2005 |